Max Healthcare Institute financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹2,366cr+16.7% on Q1 FY26
Net profit
₹323cr+4.9% on Q1 FY26
EBITDA margin
25.3%−0.5 pts on Q1 FY26
EPS
₹3.32+4.7% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue2,3662,028+16.7%
EBITDA598523+14.4%
EBITDA margin25.3%25.8%−0.5 pts
Profit before tax436400+9.0%
Net profit323308+4.9%
EPS₹3.32₹3.17+4.7%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹2,366 crNet profit₹323 crNet margin13.7%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
82,862————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
66666666298042.8
3,4783,4783,0101,299689
85,675————
8,7128,3737,0285,4064,563
—+19.1%+30.0%+18.5%—
2,3182,2431,8491,4921,241
26.6%26.8%26.3%27.6%27.2%
1,8441,7961,4891,2471,008
1,4571,4421,0761,0581,104
16.7%17.2%15.3%19.6%24.2%
₹14.98₹14.82₹11.06₹10.80₹11.34
—+34.1%+2.3%−4.7%—
—1,6331,4601,1221,209
—−1,485−966−779−336
149149494343874
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MAXHEALTH₹851.50

Max Healthcare Institute Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISMEDANTADRREDDYCIPLASUNPHARMADIVISLABTORNTPHARMMcap ₹82,862 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————82,862.0
- Cash, Equiv & ST Investments42.8979.8661.6665.8665.8
+ Total Debt689.01,299.03,010.33,478.43,478.4
Enterprise Value————85,674.6
Revenue4,562.65,406.07,028.58,373.58,712.1
Growth %, YoY—+18.5+30.0+19.1—
EBITDA1,240.51,492.11,848.82,242.82,318.4
Margin %27.1927.6026.3026.7926.61
EBIT1,008.31,247.11,489.41,796.31,844.3
Net Income1,103.51,057.61,075.91,442.41,457.4
Margin %24.1919.5615.3117.2316.73
EPS, Adj (current shares)11.3410.8011.0614.8214.98
Growth %, YoY—-4.7+2.3+34.1—
Cash from Operations1,209.21,121.81,459.71,633.3—
Capital Expenditures-335.6-778.8-965.5-1,484.5—
Free Cash Flow873.6343.0494.1148.8148.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.

Max Healthcare Institute financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Max Healthcare Institute (NSE: MAXHEALTH) had a market capitalisation of ₹82,837 crore at the 29 October 2026 close (₹851.15 a share), a PE ratio of 56.8 on the last four quarters' profit and a price-to-book ratio of 7.71. In FY26 its consolidated net profit was ₹1,442 crore on revenue of ₹8,373 crore; in Q1 FY27 (April–June 2026) it was ₹323 crore, up 4.9% year on year. Its debt-to-equity ratio was 0.32 on 31 March 2026. Promoters held 23.71% of the shares on 30 September 2026.

Share price used
₹851.15 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026
Share price and live chart
₹851.15 · 29 Oct close

Max Healthcare Institute at a glance · consolidated

Market cap
₹82,837 Crat ₹851.15 · 29 Oct close
PE ratio (last 4 quarters)
56.857.4 on FY26 profit
Price to book (PB)
7.71book value ₹110.42 a share
ROE (FY26)
14.3%+2.2 pts vs FY25ROCE 12.6%
Debt to equity
0.32net debt ₹2,778 Cr
Promoter holding
23.71%unchanged vs 30 Jun 202630 September 2026
Dividend yield
0.23%₹2 a share in 12 months
Net worth
₹10,747 Cr+14.6% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹149 Cr−69.9% vs FY25

Questions

What is the Max Healthcare Institute PE ratio today?

Max Healthcare Institute's PE ratio is 56.8 at the 29 October 2026 close (₹851.15 a share): a market capitalisation of ₹82,837 crore divided by consolidated net profit of ₹1,457 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹1,442 crore) it is 57.4.

What is the Max Healthcare Institute PB ratio (price to book value)?

Max Healthcare Institute's price-to-book (PB) ratio is 7.71 at the 29 October 2026 close: a market capitalisation of ₹82,837 crore divided by shareholders' equity (book value) of ₹10,747 crore on 31 March 2026. That is a book value of ₹110.42 per share against a share price of ₹851.15.

What is the Max Healthcare Institute net worth?

Max Healthcare Institute's net worth — shareholders' equity in its consolidated balance sheet — was ₹10,747 crore on 31 March 2026, up 14.6% from ₹9,381 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹82,837 crore at the 29 October 2026 close.

What is the Max Healthcare Institute market cap?

Max Healthcare Institute's market capitalisation was ₹82,837 crore at the 29 October 2026 close: 97.32 crore shares at ₹851.15 each.

Is Max Healthcare Institute debt free?

No. Max Healthcare Institute had borrowings of ₹3,478 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.32. Its cash and current investments were ₹701 crore, so its net debt was ₹2,778 crore.

What is the Max Healthcare Institute EPS?

Max Healthcare Institute's basic earnings per share (EPS) were ₹14.83 in FY26, against ₹11.07 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹14.99.

What is the Max Healthcare Institute debt to equity ratio?

Max Healthcare Institute's debt-to-equity ratio was 0.32 on 31 March 2026: borrowings of ₹3,478 crore against total equity of ₹10,747 crore. A year earlier, on 31 March 2025, it was 0.32.

What is the Max Healthcare Institute book value per share?

Max Healthcare Institute's book value per share was ₹110.42 on 31 March 2026: shareholders' equity of ₹10,747 crore divided by the 97.32 crore shares in issue, up 14.4% from ₹96.50 a year earlier. The share price at the 29 October 2026 close was ₹851.15.

What is the Max Healthcare Institute dividend yield?

Max Healthcare Institute's dividend yield is 0.23% at the 29 October 2026 close: dividends of ₹2 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹851.15. They were ₹2 on 3 July 2026.

What is the Max Healthcare Institute ROE and ROCE?

In FY26, Max Healthcare Institute's return on equity (ROE) was 14.3% and its return on capital employed (ROCE) was 12.6%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 12.1% and ROCE 12.3%.

What is the Max Healthcare Institute promoter holding?

Promoters held 23.71% of Max Healthcare Institute on 30 September 2026, unchanged from the previous quarter and down 0.03 percentage points from 23.74% a year earlier, according to the shareholding pattern filed with NSE.

What is the Max Healthcare Institute shareholding pattern?

On 30 September 2026, Max Healthcare Institute's shares were held by promoters 23.71%, foreign portfolio investors (FII/FPI) 40.52%, domestic institutions (DII) 31.00% (including mutual funds at 19.25%) and retail and other non-institutional investors 4.76%. Over the year, FII holding was down 11.28 percentage points from 51.80% and DII holding was up 10.97 percentage points from 20.03%.

What is the Max Healthcare Institute dividend in 2026 and its record date?

In 2026, Max Healthcare Institute has declared one dividend: ₹2 with record date 3 July 2026.

What is the Max Healthcare Institute free cash flow?

In FY26, Max Healthcare Institute generated ₹1,633 crore of cash from operations and spent ₹1,485 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹149 crore. In FY25 it was ₹494 crore.

When are the Max Healthcare Institute next results?

Max Healthcare Institute will announce its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026, the date of the board meeting it has notified to the exchanges.

What are the Max Healthcare Institute latest quarterly results?

Max Healthcare Institute's latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net profit ₹323 crore, up 4.9% from ₹308 crore in Q1 FY26; revenue from operations ₹2,366 crore, up 16.7% year on year.

What is the Max Healthcare Institute revenue and profit in FY26?

In FY26 (April 2025–March 2026), Max Healthcare Institute's consolidated net profit was ₹1,442 crore, up 34.1% from ₹1,076 crore in FY25, on revenue from operations of ₹8,373 crore (up 19.1%). Over three years, from FY23, net profit was up 30.7%.

Max Healthcare Institute vs Apollo Hospitals Enterprise: how do they compare?

In FY26, Max Healthcare Institute earned net profit of ₹1,442 crore on revenue of ₹8,373 crore, against ₹1,942 crore on ₹25,229 crore for Apollo Hospitals Enterprise. Max Healthcare Institute's operating margin was 21.5% (Apollo Hospitals Enterprise 11.5%) and its return on equity 14.3% (Apollo Hospitals Enterprise 22.0%). At the 29 October 2026 close, Max Healthcare Institute's market capitalisation was ₹82,837 crore against ₹1,17,916 crore for Apollo Hospitals Enterprise, and its PE ratio on FY26 profit 57.4 against 60.7.

How does Max Healthcare Institute compare with its peers?

On FY26 consolidated figures, against Apollo Hospitals Enterprise, Fortis Healthcare and Global Health: Max Healthcare Institute's operating margin of 21.5% is the highest of the four (Apollo Hospitals Enterprise 11.5%, Fortis Healthcare 17.9%, Global Health 15.8%; peer average 15.1%); its return on equity of 14.3% is the third highest of the four (Apollo Hospitals Enterprise 22.0%, Fortis Healthcare 11.1%, Global Health 15.2%; peer average 16.1%); its revenue growth over three years of 22.4% a year is the highest of the four (Apollo Hospitals Enterprise 14.9% a year, Fortis Healthcare 13.2% a year, Global Health 17.9% a year; peer average 15.3% a year).

Where do these Max Healthcare Institute figures come from?

From Max Healthcare Institute's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.